Deadline: 29-May-25
The Pfizer Foundation is requesting grant proposals to support Quality Improvement initiatives that identify and address gaps in adult vaccinations, improve and optimize access and immunization practices, leading to an increased vaccination coverage among the high-risk, immunocompromised adult and elderly populations.
Areas of Interest
- Potential applicants are encouraged to address immunization practice and vaccination access gaps among at-risk, immunocompromised and/or elderly populations. This may include:
- Clinical practice to improve the immunization service quality and the access to the vaccination among at-risk or immunocompromised patients
- Novel clinical pathways, in hospital or outpatient settings, to optimize the vaccination access and immunization practices among the target populations
- Innovative solutions to monitor adult vaccination status, identify gaps and barriers in following local vaccination recommendations
- Implementation of educational tools and/or interventions to increase vaccination awareness, boost healthcare professionals’ confidence in addressing vaccine hesitancy, and educate vaccinators on disease burden and risk.
- Specific Area of Interest:
- It is their intent to support projects that focus on immunization practice and vaccination access among atrisk and immunocompromised patients, including but not limited to:
- Clinical practice improvement of the immunization service quality or the access to vaccination among at-risk, immunocompromised patients and/or elderly population
- Supporting, training and/or other educational approaches for HCPs on disease awareness, current recommendations, the value of immunization in specific subpopulations, providing tools and resources on disease burden and risk of developing severe disease among high risk individuals
- Novel and/or tailored clinical pathways in hospitals or outpatient settings optimizing, facilitating and streamlining implementation of the recommendations and access to the immunizations among atrisk or immunocompromised patients.
- It is their intent to support projects that focus on immunization practice and vaccination access among atrisk and immunocompromised patients, including but not limited to:
Funding Information
- Individual projects requesting up to 50,000 EUR will be considered.
- The estimated total available budget related to this RFP is 300,000 EUR. Larger grant amounts may be considered depending on the project scope and methodology.
- Duration: Project length will be a maximum of 18 months.
Geographical Focus
Eligibility Criteria
- The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
- The Project Lead/PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
For more information, visit The Pfizer Foundation.
